Page 324 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.14. Treatment characteristics—changes in treatment patterns over time (continued)
Author Database Treatment 1980- 1985-89 1990-94 1995- 2000-04 2005- Statistical Notes
Year 84 99 10 analysis
PMID
therapy than separately.
White men (OR
0.62 and 0.50 for
moderately and
poorly
differentiated
tumors
respectively,
P<0.001 vs.
White men),
whereas by 1999
the odds that
Hispanic men
would receive
definitive therapy
were not
significantly
different from
those of White
men (p=0.20 and
0.96 for moderate
and poorly
differentiated.
cancers,
respectively).
3. A disparity in
the use of
definitive therapy
by Black men
with moderately
or poorly
differentiated
cancers
compared to
White men
persisted in 1999
(OR 0.60 and
0.45,
respectively,

C-80